ES2504540T3 - Composición para aplicación cutánea externa - Google Patents

Composición para aplicación cutánea externa Download PDF

Info

Publication number
ES2504540T3
ES2504540T3 ES08703827.9T ES08703827T ES2504540T3 ES 2504540 T3 ES2504540 T3 ES 2504540T3 ES 08703827 T ES08703827 T ES 08703827T ES 2504540 T3 ES2504540 T3 ES 2504540T3
Authority
ES
Spain
Prior art keywords
composition
external skin
skin application
aminoacetoamide
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08703827.9T
Other languages
English (en)
Inventor
Mikiko Kaminuma
Masaru Suetsugu
Nobuhiko Ochiai
Makoto Tsunenaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Application granted granted Critical
Publication of ES2504540T3 publication Critical patent/ES2504540T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)

Abstract

Una composición para aplicación cutánea externa, que contiene un compuesto de aminoacetoamida representado por la fórmula general (1)**Fórmula** o una sal del mismo, donde la cantidad de compuesto de aminoacetoamida representado por la fórmula general (1), o de la sal del mismo, oscila entre 0,001 y 20% en peso, en base al peso total de la composición.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13

Claims (1)

  1. imagen1
ES08703827.9T 2007-01-25 2008-01-24 Composición para aplicación cutánea externa Active ES2504540T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007015083 2007-01-25
JP2007015083 2007-01-25
PCT/JP2008/051000 WO2008090962A1 (ja) 2007-01-25 2008-01-24 皮膚外用組成物

Publications (1)

Publication Number Publication Date
ES2504540T3 true ES2504540T3 (es) 2014-10-08

Family

ID=39644536

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08703827.9T Active ES2504540T3 (es) 2007-01-25 2008-01-24 Composición para aplicación cutánea externa

Country Status (8)

Country Link
US (1) US8138374B2 (es)
EP (1) EP2123251B1 (es)
JP (1) JP5235423B2 (es)
KR (1) KR101345460B1 (es)
CN (1) CN101578091B (es)
ES (1) ES2504540T3 (es)
HK (1) HK1137331A1 (es)
WO (1) WO2008090962A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103126063B (zh) * 2011-11-23 2016-02-17 福建中烟工业有限责任公司 一种烟草感官保润剂及其在烟草中的使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
JP3441387B2 (ja) * 1998-12-18 2003-09-02 カネボウ株式会社 保湿剤及び皮膚化粧料並びに入浴剤
FR2821551B1 (fr) 2001-03-05 2004-05-14 Oreal Utilisations de derives de polyaminoacides comme agents hydratants, et compositions cosmetiques ou pharmaceutiques les comprenant

Also Published As

Publication number Publication date
CN101578091A (zh) 2009-11-11
US8138374B2 (en) 2012-03-20
JP2008201775A (ja) 2008-09-04
EP2123251B1 (en) 2014-09-17
WO2008090962A1 (ja) 2008-07-31
US20100094054A1 (en) 2010-04-15
KR101345460B1 (ko) 2013-12-27
EP2123251A4 (en) 2012-12-12
HK1137331A1 (en) 2010-07-30
JP5235423B2 (ja) 2013-07-10
KR20090104067A (ko) 2009-10-05
CN101578091B (zh) 2011-11-16
EP2123251A1 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
ES2633317T3 (es) Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
ES2566391T3 (es) Composiciones a base de hidrofluoroolefinas
ES2525481T3 (es) Derivados espirocíclicos de ácido tetrónico
ES2548578T3 (es) Monosebacato de un derivado de pirazol
PE20120250A1 (es) Composicion farmaceutica que comprende derivados de glucopiranosil difenilmetano, forma farmaceutica de la misma, procedimiento para su preparacion
BRPI0621386B8 (pt) composição farmacêutica para o uso externo
CL2012002526A1 (es) Uso de compuestos inhibidores de dpp iv de formula (i) o (ii) o una de sus sales, para el tratamiento de falla cardiaca.
ECSP109922A (es) Compuestos de pirazol y su uso como inhibidores raf
ES2546198T3 (es) Tratamiento contra la glomerulonefritis
ES2532451T3 (es) Composición herbicida
CO6430460A2 (es) Compuestos tetraciclicos
CL2008003690A1 (es) Compuestos derivados de amonobenzamida; composicion farmceutica que comprende los compuestos; y uso para controlar parasitos.
ATE541865T1 (de) Fotoinitiatormischungen
ECSP088859A (es) Nueva forma cristalina vi de la agomelatina, su procedimiento de preparación y las composiciones farmacéuticas que la contienen
AR064736A1 (es) Agonistas de gpcr
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
UY32096A (es) Derivados de 2-carboxamida - cicloamino - urea especìficos, sus sales farmacèuticamente aceptables, composiciones contenièndolos, pro-farmacos de los mismos, procesos para su produciòn y aplicaciones
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
ES2531009T3 (es) Análogos sustituidos de dicetopiperazina para su uso como agentes para la administración de fármacos
RS53003B (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
TR201902435T4 (tr) DGAT1 inhibitör içeren farmasötik bileşimler.
RU2012148909A (ru) Новый синтез соединений тиазолидиндиона
ES2501595T3 (es) Plancha litográfica de aluminio
UA106880C2 (uk) Нові гербіциди
AR081819A1 (es) Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades